Ovarian cancer-derived IL-4 promotes immunotherapy resistance
Gürkan Mollaoglu(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Dmitriy Zamarin(Tisch Hospital), Matthew D. Park(Icahn School of Medicine at Mount Sinai), Alessia Baccarini(Icahn School of Medicine at Mount Sinai), Alexander Tepper(Broad Institute), Noam Rabinovich(Data & Society Research Institute), Jia‐Ren Lin(Harvard University), Lindsay Browning(Brigham and Women's Hospital), Sandro Santagata(Harvard University), Peter K. Sorger(Harvard University Press), Nelson M. LaMarche(Icahn School of Medicine at Mount Sinai), Jaime Mateus-Tique(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Chiara Falcomatà(Icahn School of Medicine at Mount Sinai), Luisanna Pia(Icahn School of Medicine at Mount Sinai), Rachel Brody(Icahn School of Medicine at Mount Sinai), Hunter Potak(Icahn School of Medicine at Mount Sinai), Angelo Amabile(Icahn School of Medicine at Mount Sinai)
Cited by 99
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k